Results 181 to 190 of about 3,775,993 (302)

Factors Associated With The Initiation Of Biologic Disease Modifying Antirheumatic Drugs In Texas Medicaid Patients With Rheumatoid Arthritis [PDF]

, 2014
G. Kim, Jamie C. Barner, KL Rascati, Kristin M. Richards   +3 more
openalex   +1 more source

Impact of Disease-Modifying Antirheumatic Drugs on Cognitive Function in Older Adults with Rheumatoid Arthritis. [PDF]

Drugs Aging
Fazel SD, Carollo M, Tap L, Spini A, Trifirò G, Mattace-Raso FUS.   +5 more
europepmc   +1 more source

Lipid profiles in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs [PDF]

, 2014
Anna Filipowicz‐Sosnowska, Piotr Głuszko, Robert Rupiński   +2 more
openalex   +1 more source

Real-World Treatment Effectiveness of Disease-Modifying Antirheumatic Drugs by Serostatus Among Patients With Rheumatoid Arthritis. [PDF]

ACR Open Rheumatol, 2023
Jin Y, Liu J, Desai RJ, Kim SC.
europepmc   +1 more source

Joint Damage Progression in Patients with Rheumatoid Arthritis in Clinical Remission. Do Biologics Perform Better Than Synthetic Antirheumatic Drugs? [PDF]

, 2014
Elena Ciubotariu, Cem Gabay, Axel Finckh
openalex   +1 more source

Comparison of the Efficacy and Safety of Disease-Modifying Antirheumatic Drugs Combination Therapies: A Systematic Review and Network Meta-Analysis. [PDF]

Clin Transl Sci
Liu L, Ambe K, Onishi M, Yoshii Y, Makino T, Tohkin M.   +5 more
europepmc   +1 more source

Withdrawal of disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis

, 2009
Rachel O’Mahony, Mark Richards, C. Deighton, D. G. I. Scott   +3 more
openalex   +1 more source

Facilitators and Barriers to Adherence in the Initiation Phase of Disease-modifying Antirheumatic Drug (DMARD) Use in Patients with Arthritis Who Recently Started Their First DMARD Treatment [PDF]

, 2014
Annelieke Pasma, Adriaan van ’t Spijker, Jolanda J. Luime, Margot Walter, Jan J.V. Busschbach, Johanna M W Hazes   +5 more
openalex   +1 more source

Pregnancy Outcomes of Targeted Synthetic Disease-Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review. [PDF]

Arthritis Care Res (Hoboken)
Cheng V, Amiri N, Cheng V, Ellis U, Cragg JJ, Harrison M, Proulx L, De Vera MA.   +7 more
europepmc   +1 more source

Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs [PDF]

, 2014
Tsutomu Takeuchi, Tsukasa Matsubara, Yukitomo Urata, Eiichi Suematsu, Shuji Ohta, Shigeru Honjo, Tohru Abe, Ami Yamamoto, Nobuyuki Miyasaka   +8 more
openalex   +1 more source